Business Context and Reporting Period
Company: Flotek Industries, Inc. (FTK)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended June 30, 2025
Business Overview: Flotek operates two segments: Chemistry Technologies (CT), providing optimized chemistry solutions for the energy sector, and Data Analytics (DA), offering real-time operational insights and emissions reduction technology. The company is a non-accelerated filer and smaller reporting company.
Key Financial Metrics
| Metric (in thousands) | Q2 2025 | Q2 2024 | YTD 2025 | YTD 2024 |
|---|---|---|---|---|
| Total Revenue | $58,350 | $46,152 | $113,712 | $86,526 |
| Gross Profit | $14,407 | $9,170 | $26,856 | $17,991 |
| Gross Margin | 24.7% | 19.9% | 23.6% | 20.8% |
| Net Income | $1,768 | $1,974 | $7,148 | $3,536 |
| Operating Cash Flow (YTD) | $2,822 | $827 | $2,822 | $827 |
| Cash & Equivalents (End of Period) | $5,028 | $4,777 | $5,028 | $4,777 |
| Total Debt (Current + Long Term) | $44,737 | $4,849 | $44,737 | $4,849 |
Note: Total Debt includes $5.1M Asset-Based Loan and $39.5M related party note (net of deferred costs).
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 26% in Q2 2025 and 31% YTD compared to 2024. This was driven by higher external customer sales volumes, increased related party activity, and $3.2M in new rental revenue from the PWRtek Transactions.
- Asset Acquisition: On April 28, 2025, the company acquired mobile power generation assets from a related party (ProFrac GDM) for total consideration of $107.5M. This included a $40M secured promissory note, a warrant for 6M shares, and offsets against contract shortfall fees. The assets were recorded at historical book value ($15.1M) due to common control, with the excess consideration reducing equity.
- Segment Performance:
- Chemistry Technologies (CT): Operating income increased to $8.0M (Q2) and $16.9M (YTD) due to higher product volumes.
- Data Analytics (DA): Operating loss widened to $(1.9M) (Q2) and $(2.0M) (YTD) primarily due to $4.2M in asset acquisition expenses and increased material costs, partially offset by new rental income.
- Contract Shortfall Fees: The company expects minimum purchase requirements under the ProFrac Agreement to be unmet for 2025. Related party revenue for YTD 2025 includes $15.2M in accrued Contract Shortfall Fees.
Guidance, Outlook, and Risks
- Outlook: Management anticipates stable demand for chemistry products in 2025 based on current oil and gas prices and customer commitments. The company expects the new Lease Agreement to significantly impact future DA segment financial results.
- Liquidity: The company believes cash on hand, operating cash flow, and availability under its Asset-Based Loan (ABL) are sufficient for the next 12 months. As of June 30, 2025, approximately $9.2M was available under the ABL.
- Risks & Contingencies:
- Customer Concentration: A single related party (ProFrac Services) accounted for 56.8% of Q2 2025 revenue. The company's liquidity is heavily dependent on the ProFrac Agreement and the new Lease Agreement.
- Debt Covenants: The ABL requires the company to maintain positive trailing three-month consolidated net income through December 31, 2025. The Tangible Net Worth covenant is waived through this date.
- Regulatory: The company expects to become an "accelerated filer" by December 31, 2025, requiring an attestation report on internal controls.
Investor Verification Checklist
- Related Party Dependence: Verify the sustainability of revenue from ProFrac Services (56.8% of Q2 revenue) and the collectability of accrued Contract Shortfall Fees.
- Debt Structure: Review the terms of the new $40M PWRtek Note (10% interest, PIK option) and its impact on future interest expense and cash flow.
- Asset Valuation: Confirm the accounting treatment of the $107.5M asset acquisition, specifically the reduction of equity due to the excess consideration over historical book value.
- Covenant Compliance: Monitor the company's ability to maintain positive trailing three-month net income to satisfy ABL covenants through year-end 2025.
- Warrant Dilution: Assess the potential dilution from the April 2025 Warrant (6M shares) and June 2022 Warrants.